The rising cost of generic drugs
Worth, T.
Medical Economics 92(5): 36-39
2015
ISSN/ISBN: 0025-7206 PMID: 26299038 Document Number: 679030
Document emailed within 1 workday
Related Documents
Szuba, T. 1987: Cost evaluation of branded and generic drugs Materia Medica Polona. Polish Journal of Medicine and Pharmacy 19(2): 137-142Ansa Erice, I.; Agudo Pascual, C.; Artazcoz Sanz, M.; Carnicero Giménez de Azcárate, J. 1996: Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra Atencion Primaria 17(6): 411-414
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Gouveia, W.A. 1993: The rising cost of pharmaceuticals: understanding and managing the escalating cost of pharmaceuticals in health care institutions. Executive summary American Journal of Hospital Pharmacy 50(8 Suppl. 4): S2-S3
Bangalee, V; Suleman, F 2016: Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Health Sa Gesondheid 21: 60-66
Rothman, D.J. 1993: The rising cost of pharmaceuticals: an ethicist's perspective American Journal of Hospital Pharmacy 50(Suppl. 4): S10-S12
Pierpaoli, P.G. 1993: The rising cost of pharmaceuticals: a director of pharmacy's perspective American Journal of Hospital Pharmacy 50(8 Suppl. 4): S6-S8
Shorb, G.S. 1993: The rising cost of pharmaceuticals: a hospital executive's perspective American Journal of Hospital Pharmacy 50(8 Suppl 4: S4-S6
Kaufer, E. 1980: 3 reasons for the rising cost of health care. Why costs are exploding Die Medizinische Welt 31(1): XXVIII-XXVXXX
Zapater, P.; Horga, J.F. 2000: Bio-equivalence and generic drugs. Studies of bio-equivalence. II. Special situations. Reflections on problems which may arise with drugs habitually used in neurology Revista de Neurologia 30(2): 146-154
Katz, A.; Zalzstein, E. 2001: Generic antiarrhythmics: safety and efficacy versus cost Harefuah 140(11): 1087-1090
Jensen, J. 1991: Consumers trail other groups in concern over healthcare cost, but interest is rising Modern Healthcare 21(9): 50; 52
Ayd, F.J. 1978: Generic drugs Journal of Clinical Psychiatry 39(10): 789
García-Arieta, A.; Blázquez-Pérez, A.; de la Barrera, P.P.; Pozo-Hernández, C.; Vargas-Castrillón, E. 2006: Regarding generic antiepileptic drugs Revista de Neurologia 43(7): 446-8; Author Reply 448
Mack, R.B. 1988: Concern about generic drugs North Carolina Medical Journal 49(12): 665
2002: Generic drugs. Understanding their value Mayo Clinic Health Letter 20(1): 7
Tremblay, J. 1980: Prescription drugs and the aged: cost-free and cost-containment measures L'Union Medicale du Canada 109(3): 414-420
Gogtay, J.A. 2007: The impact of generic antiviral drugs Idrugs: the Investigational Drugs Journal 10(12): 881-884
Taylor, J.M. 1978: Color scheme for generic drugs New England Journal of Medicine 298(20): 1152